Fischer Medical [FISCHER] vs HSIL Limited [HSIL] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Fischer Medical wins in 4 metrics, HSIL Limited wins in 7 metrics, with 0 ties. HSIL Limited appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricFischer MedicalHSIL LimitedBetter
P/E Ratio (TTM)1,197.2218.70HSIL Limited
Price-to-Book Ratio35.60N/AN/A
Debt-to-Equity Ratio25.2789.90Fischer Medical
PEG Ratio-8.26N/AN/A
EV/EBITDA849.1320.08HSIL Limited
Profit Margin (TTM)5.26%72.43%HSIL Limited
Operating Margin (TTM)14.89%N/AN/A
EBITDA Margin (TTM)14.89%N/AN/A
Return on Equity0.36%1,493.74%HSIL Limited
Return on Assets (TTM)0.26%7.66%HSIL Limited
Free Cash Flow (TTM)$-927.26MN/AN/A
1-Year Return59.80%-5.02%Fischer Medical
Price-to-Sales Ratio (TTM)55.673.75HSIL Limited
Enterprise Value$67.25B$64.93BFischer Medical
EV/Revenue Ratio53.584.54HSIL Limited
Gross Profit Margin (TTM)45.56%-49.38%Fischer Medical
Revenue per Share (TTM)$1N/AN/A
Earnings per Share (Diluted)$0.09N/AN/A
Beta (Stock Volatility)0.00N/AN/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Fischer Medical vs HSIL Limited Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Fischer Medical-0.51%-5.37%-0.47%26.96%29.19%52.48%
HSIL Limited2.46%1.73%0.62%8.75%14.32%-20.00%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Fischer Medical59.80%893.99%3,779.06%1,435.00%-66.84%527.63%
HSIL Limited-5.02%168.26%1,142.71%996.46%2,189.53%3,363.84%

News Based Sentiment: Fischer Medical vs HSIL Limited

Fischer Medical

News based Sentiment: POSITIVE

September was a remarkably positive month for Fischer Medical Ventures, driven by exceptional financial results, a successful listing on the NSE, and a shareholder-friendly stock split. These developments signal strong growth and investor confidence, making it a significant period for the company's investment story.

View Fischer Medical News Sentiment Analysis

HSIL Limited

News based Sentiment: MIXED

September presented a mixed bag for HSIL and AGI Greenpac, with positive developments like brand expansion and analyst upgrades offset by concerning quarterly results and stock performance. The potential fundraising indicates a need for capital, while the strategic focus on the luxury market suggests a long-term growth strategy, creating a complex investment picture.

View HSIL Limited News Sentiment Analysis

Performance & Financial Health Analysis: Fischer Medical vs HSIL Limited

MetricFISCHERHSIL
Market Information
Market Cap i₹69.68B₹53.70B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i31,86957,776
90 Day Avg. Volume i46,25989,766
Last Close₹107.45₹886.05
52 Week Range₹60.01 - ₹124.20₹599.10 - ₹1,307.90
% from 52W High-13.49%-32.25%
All-Time High₹2,386.00 (Apr 21, 2008)₹1,307.90 (Dec 16, 2024)
% from All-Time High-95.50%-32.25%
Growth Metrics
Quarterly Revenue Growth1.32%-1.27%
Quarterly Earnings GrowthN/AN/A
Financial Health
Profit Margin (TTM) i0.05%0.72%
Operating Margin (TTM) i0.15%N/A
Return on Equity (TTM) i0.00%14.94%
Debt to Equity (MRQ) i25.2789.90
Cash & Liquidity
Book Value per Share (MRQ)₹3.03N/A
Cash per Share (MRQ)₹3.94N/A
Operating Cash Flow (TTM) i₹-1,020,336,000₹686.00M
Levered Free Cash Flow (TTM) i₹12.08M₹1.93B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A₹0.00

Valuation & Enterprise Metrics Analysis: Fischer Medical vs HSIL Limited

MetricFISCHERHSIL
Price Ratios
P/E Ratio (TTM) i1,197.2218.70
Forward P/E iN/A15.71
PEG Ratio i-8.26N/A
Price to Sales (TTM) i55.673.75
Price to Book (MRQ) i35.60N/A
Market Capitalization
Market Capitalization i₹69.68B₹53.70B
Enterprise Value i₹67.25B₹64.93B
Enterprise Value Metrics
Enterprise to Revenue i53.584.54
Enterprise to EBITDA i849.1320.08
Risk & Other Metrics
Beta i0.00N/A
Book Value per Share (MRQ) i₹3.03N/A

Financial Statements Comparison: Fischer Medical vs HSIL Limited

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)FISCHERHSIL
Revenue/Sales i₹234.45MN/A
Cost of Goods Sold i₹127.64MN/A
Gross Profit i₹106.81MN/A
Research & Development iN/AN/A
Operating Income (EBIT) i₹34.90MN/A
EBITDA i₹117.28MN/A
Pre-Tax Income i₹101.75MN/A
Income Tax i₹51.67MN/A
Net Income (Profit) i₹50.08MN/A

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)FISCHERHSIL
Cash & Equivalents i₹1.04BN/A
Total Current Assets i₹3.65BN/A
Total Current Liabilities i₹1.02BN/A
Long-Term Debt i₹172.06MN/A
Total Shareholders Equity i₹3.38BN/A
Retained Earnings i₹29.05MN/A
Property, Plant & Equipment i₹89.03MN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)FISCHERHSIL
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricFISCHERHSIL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i31,86957,776
Average Daily Volume (90 Day) i46,25989,766
Shares Outstanding i638.02M64.70M
Float Shares i147.07MN/A
% Held by Insiders i0.76%N/A
% Held by Institutions i0.03%N/A

Dividend Analysis & Yield Comparison: Fischer Medical vs HSIL Limited

MetricFISCHERHSIL
Last 12-Month Dividend iN/A₹0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A₹0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A₹0.00
Ex-Dividend DateN/AN/A